Regulatory Mechanism of PD-L1 Expression in Primary Liver Cancer
The application of immunotherapy has become a hot spot in tumor research currently. In particular, immune checkpoint inhibitors have played an important role in the treatment of advanced unresectable primary liver cancer. However, the efficacy of immune checkpoint inhibitors varies greatly in the tr...
Enregistré dans:
Auteurs principaux: | LI Shenghao, SHI Xinli |
---|---|
Format: | article |
Langue: | ZH |
Publié: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aeb6ca2b49204a9f9fbb56777e5f963a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
par: Zhitao Li, et autres
Publié: (2021) -
Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
par: Xiangdong Ye, et autres
Publié: (2021) -
Visual Analysis and Focused Areas of Immunotherapy for Liver Cancer Based on Literature Data
par: YANG Xi, et autres
Publié: (2021) -
Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
par: Jianyu Liu, et autres
Publié: (2021) -
Dl-3-N-Butylphthalide Presents Anti-Cancer Activity in Lung Cancer by Targeting PD-1/PD-L1 Signaling
par: Jiang Q, et autres
Publié: (2021)